Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test

The Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV combination test received emergency use authorization approval by the United States Food and Drug Administration in December 2020, and Health Canada approval in January 2021. The performance characteristics of the GeneXpert Xpert Xpress SARS-CoV-2/Flu/RSV...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Journal of Clinical Virology Plus
Main Authors: Johnson, Grant, Zubrzycki, Arek, Henry, Michele, Ranadheera, Charlene, Corbett, Cindi, Meyers, Adrienne F.A., Sandstrom, Paul A., Becker, Michael G.
Formato: Artigo
Idioma:Inglês
Publicado: The Authors. Published by Elsevier Ltd. 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040320/
https://ncbi.nlm.nih.gov/pubmed/35262002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcvp.2021.100014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares